Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents
Ayoub Aghcheli, Mahsa Toolabi, Adileh Ayati, et al.
Medicinal Chemistry Research (2020) Vol. 29, Iss. 11, pp. 2000-2010
Closed Access | Times Cited: 25

Showing 25 citing articles:

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113523-113523
Closed Access | Times Cited: 76
The Different Facets of Triclocarban: A Review
Domenico Iacopetta, Alessia Catalano, Jessica Ceramella, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2811-2811
Open Access | Times Cited: 55
One-Pot quaternization strategy for novel Poly(pyridinium-acetamide) ionic polymers as potential anticancer and anti-microbial agents
Salsabeel Al-Sodies, Mahmoud A. Hussein, Abdullah M. Asiri, et al.
European Polymer Journal (2025), pp. 113729-113729
Closed Access
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9795-9811
Closed Access | Times Cited: 14
Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
A novel 1,3,4-thiadiazole modified chitosan: synthesis, characterization, antimicrobial activity, and release study from film dressings
Ahmad E. Mohamed, Walid E. Elgammal, Aya M. Dawaba, et al.
Applied Biological Chemistry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 18
New Functionalized Chitosan with Thio-Thiadiazole Derivative with Enhanced Inhibition of Pathogenic Bacteria, Plant Threatening Fungi, and Improvement of Seed Germination
Ahmed G. Ibrahim, Walid E. Elgammal, Ahmed M. Eid, et al.
Chemistry (2023) Vol. 5, Iss. 3, pp. 1722-1744
Open Access | Times Cited: 7
Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity
Aram Faraji, Rasoul Motahari, Zaman Hasanvand, et al.
Bioorganic Chemistry (2020) Vol. 108, pp. 104553-104553
Closed Access | Times Cited: 22
Sulphur Containing Heterocyclic Compounds as Anticancer Agents
Vikas Sharma, Balwinder Kaur, Gurdeep Singh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 869-881
Closed Access | Times Cited: 10
Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers
Hazem A. Mahdy, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 139019-139019
Closed Access | Times Cited: 1
Thiadiazole-thiazole derivatives as potent anti-tubercular agents: Synthesis, biological evaluation, and In silico docking studies
Samin A. Shaikh, Shivaji R. Labhade, Raju R. Kale, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100183-100183
Open Access | Times Cited: 1
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studies
Hazem Elkady, Walid E. Elgammal, Hazem A. Mahdy, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108221-108221
Closed Access | Times Cited: 1
Design, synthesis, antiproliferative and antimicrobial evaluation of a new class of disulfides containing 1,3,4-thiadiazole units
Ruilian Zhang, Бо Ли, Chun-Lan Chi, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 9, pp. 1571-1583
Closed Access | Times Cited: 8
Thienopyrimidine‐based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity
Esmail Mohammadian, Tayebeh Oghabi Bakhshaiesh, Abolghasem Jouyban, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Closed Access | Times Cited: 7
Synthesis of novel 2‐acetamide‐5‐phenylthio‐1,3,4‐thiadiazole‐containing phenyl urea derivatives as potential VEGFR‐2 inhibitors
Mahsa Toolabi, Fatemeh Safari, Adileh Ayati, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 3
Closed Access | Times Cited: 5
Design, synthesis, and screening for the antiproliferative activity of new 1,3,4-thiadiazole scaffold linked to substituted phenacyl derivatives and disulfides
Yang Liu, Junjie Li, Xuguang Liu, et al.
Journal of Sulfur Chemistry (2022) Vol. 43, Iss. 4, pp. 426-442
Closed Access | Times Cited: 5
Synthesis and Biological Evaluation of 12-Aryl-11-hydroxy-5,6-dihydropyrrolo[2″,1″:3′,4′]pyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-8(9H)-one Derivatives as Potential Cytotoxic Agents
Azam Barghi Lish, Alireza Foroumadi, Eskandar Kolvari, et al.
ACS Omega (2023) Vol. 8, Iss. 45, pp. 42212-42224
Open Access | Times Cited: 2
Development of optimized pyrimido-thiazole scaffold derivatives as anticancer and multitargeting tyrosine kinase inhibitors using computational studies
Kalyani D. Asgaonkar, Sushruti Tanksali, Kshitija Abhang, et al.
Journal of the Indian Chemical Society (2022) Vol. 100, Iss. 1, pp. 100803-100803
Open Access | Times Cited: 4
Medicinal attributes of thienopyrimidine scaffolds incorporating the aryl urea motif as potential anticancer candidates via VEGFR inhibition
Myrna A. Farag, Manal M. Kandeel, Asmaa E. Kassab, et al.
Archiv der Pharmazie (2024)
Closed Access
A deep learning model based on the BERT pre-trained model to predict the antiproliferative activity of anti-cancer chemical compounds
Meysam Torabi, Ismaeil Haririan, Alireza Foroumadi, et al.
SAR and QSAR in environmental research (2024), pp. 1-22
Closed Access
New thiazolidin-4-ones as anti-cervical cancer agents targeting EGFR: design, synthesis, and computational studies
Wafa A. Bawazir, Nesreen S. Ahmed, Somaia S. Abd El‐Karim, et al.
Future Medicinal Chemistry (2024), pp. 1-17
Closed Access
Mechanistic elucidation and prediction of the anticancer activity of 1,3,4-thiadiazol-2-amide derivatives
R. Zeng, Fenglian Liu, Shiyi Shen, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132228-132228
Closed Access | Times Cited: 5
Synthesis, Antifungal Activity and Molecular Docking Study of 1,3,4-Thiadiazole-Urea Compounds Containing gem-Dimethylcyclopropane Ring Structure
Yucheng Cui, Mei-Hua Chen, Lin Guishan, et al.
Chinese Journal of Organic Chemistry (2022) Vol. 42, Iss. 11, pp. 3784-3784
Open Access | Times Cited: 3
Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives
Shicheng Hou, Shishao Liang, Chao Zhang, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3496-3496
Open Access | Times Cited: 2
Preparation, diagnostics, and biological evaluation of new 1,3,4-thiadiazol derivatives
Manar Hamad Mohammed, Shaima ibraheem chyad, Salwa Abdul-Satar Jabbar
Materials Today Proceedings (2021) Vol. 61, pp. 710-716
Closed Access | Times Cited: 1
Page 1

Scroll to top